APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Glulisine Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insulin Glulisine Injection Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchInsulin Glulisine Injection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Glulisine Injection Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Insulin Glulisine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Glulisine Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Glulisine Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Insulin Glulisine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Glulisine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Glulisine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Glulisine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Glulisine Injection include Sanofi, Novo Nordisk, Eli Lilly and Company, Dongyangguang Pharmaceuticals, Gan & Lee Pharmaceuticals and Biocon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Glulisine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Glulisine Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Glulisine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Glulisine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Glulisine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Glulisine Injection Market by Company

Sanofi

Novo Nordisk

Eli Lilly and Company

Dongyangguang Pharmaceuticals

Gan & Lee Pharmaceuticals

Biocon

Insulin Glulisine Injection Segment by Type

10ml

3ml

Insulin Glulisine Injection Segment by Application

Hospital

Clinic

Others

Insulin Glulisine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Glulisine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Glulisine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Glulisine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Glulisine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Glulisine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10ml Table 2. Major Company of 3ml Table 3. Global Insulin Glulisine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Insulin Glulisine Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Insulin Glulisine Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Insulin Glulisine Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Insulin Glulisine Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Insulin Glulisine Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Insulin Glulisine Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Insulin Glulisine Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Insulin Glulisine Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Insulin Glulisine Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Insulin Glulisine Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Insulin Glulisine Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Insulin Glulisine Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Insulin Glulisine Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Insulin Glulisine Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Insulin Glulisine Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Insulin Glulisine Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Insulin Glulisine Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Insulin Glulisine Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Insulin Glulisine Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Insulin Glulisine Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Insulin Glulisine Injection Industry Trends Table 25. Insulin Glulisine Injection Industry Drivers Table 26. Insulin Glulisine Injection Industry Opportunities and Challenges Table 27. Insulin Glulisine Injection Industry Restraints Table 28. Global Insulin Glulisine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Insulin Glulisine Injection Revenue Market Share by Company (2021-2026) Table 30. Global Insulin Glulisine Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Insulin Glulisine Injection Sales Share by Company (2021-2026) Table 32. Global Insulin Glulisine Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Insulin Glulisine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Insulin Glulisine Injection Major Company Production Sites and Headquarters Table 35. Global Insulin Glulisine Injection Company, Product Type & Application Table 36. Global Insulin Glulisine Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Insulin Glulisine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Insulin Glulisine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Insulin Glulisine Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Insulin Glulisine Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Insulin Glulisine Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Insulin Glulisine Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Insulin Glulisine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Insulin Glulisine Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Insulin Glulisine Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Insulin Glulisine Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Insulin Glulisine Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Insulin Glulisine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Insulin Glulisine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Insulin Glulisine Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Insulin Glulisine Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Insulin Glulisine Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Insulin Glulisine Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Insulin Glulisine Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Insulin Glulisine Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Insulin Glulisine Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Insulin Glulisine Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Insulin Glulisine Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Insulin Glulisine Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Insulin Glulisine Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Insulin Glulisine Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Insulin Glulisine Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Insulin Glulisine Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Insulin Glulisine Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Insulin Glulisine Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Insulin Glulisine Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Insulin Glulisine Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Insulin Glulisine Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Insulin Glulisine Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Insulin Glulisine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Insulin Glulisine Injection Product Portfolio Table 75. Sanofi Recent Development Table 76. Novo Nordisk Company Information Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Insulin Glulisine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novo Nordisk Insulin Glulisine Injection Product Portfolio Table 80. Novo Nordisk Recent Development Table 81. Eli Lilly and Company Company Information Table 82. Eli Lilly and Company Business Overview Table 83. Eli Lilly and Company Insulin Glulisine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly and Company Insulin Glulisine Injection Product Portfolio Table 85. Eli Lilly and Company Recent Development Table 86. Dongyangguang Pharmaceuticals Company Information Table 87. Dongyangguang Pharmaceuticals Business Overview Table 88. Dongyangguang Pharmaceuticals Insulin Glulisine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Dongyangguang Pharmaceuticals Insulin Glulisine Injection Product Portfolio Table 90. Dongyangguang Pharmaceuticals Recent Development Table 91. Gan & Lee Pharmaceuticals Company Information Table 92. Gan & Lee Pharmaceuticals Business Overview Table 93. Gan & Lee Pharmaceuticals Insulin Glulisine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Gan & Lee Pharmaceuticals Insulin Glulisine Injection Product Portfolio Table 95. Gan & Lee Pharmaceuticals Recent Development Table 96. Biocon Company Information Table 97. Biocon Business Overview Table 98. Biocon Insulin Glulisine Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Biocon Insulin Glulisine Injection Product Portfolio Table 100. Biocon Recent Development Table 101. North America Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Insulin Glulisine Injection Sales by Country (2021-2026) & (K Units) Table 103. North America Insulin Glulisine Injection Sales Market Share by Country (2021-2026) Table 104. North America Insulin Glulisine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Insulin Glulisine Injection Sales Market Share Forecast by Country (2027-2032) Table 106. North America Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Insulin Glulisine Injection Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Insulin Glulisine Injection Market Share by Country (2021-2026) Table 109. North America Insulin Glulisine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Insulin Glulisine Injection Market Share Forecast by Country (2027-2032) Table 111. Europe Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Insulin Glulisine Injection Sales by Country (2021-2026) & (K Units) Table 113. Europe Insulin Glulisine Injection Sales Market Share by Country (2021-2026) Table 114. Europe Insulin Glulisine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Insulin Glulisine Injection Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Insulin Glulisine Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Insulin Glulisine Injection Market Share by Country (2021-2026) Table 119. Europe Insulin Glulisine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Insulin Glulisine Injection Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Insulin Glulisine Injection Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Insulin Glulisine Injection Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Insulin Glulisine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Insulin Glulisine Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Insulin Glulisine Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Insulin Glulisine Injection Market Share by Country (2021-2026) Table 129. Asia-Pacific Insulin Glulisine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Insulin Glulisine Injection Market Share Forecast by Country (2027-2032) Table 131. Latin America Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Insulin Glulisine Injection Sales by Country (2021-2026) & (K Units) Table 133. Latin America Insulin Glulisine Injection Sales Market Share by Country (2021-2026) Table 134. Latin America Insulin Glulisine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Insulin Glulisine Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Insulin Glulisine Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Insulin Glulisine Injection Market Share by Country (2021-2026) Table 139. Latin America Insulin Glulisine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Insulin Glulisine Injection Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Insulin Glulisine Injection Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Insulin Glulisine Injection Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Insulin Glulisine Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Insulin Glulisine Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Insulin Glulisine Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Insulin Glulisine Injection Market Share by Country (2021-2026) Table 149. Middle East and Africa Insulin Glulisine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Insulin Glulisine Injection Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Insulin Glulisine Injection Distributors List Table 154. Insulin Glulisine Injection Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Insulin Glulisine Injection Image Figure 2. Global Insulin Glulisine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Glulisine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Glulisine Injection Sales (2021-2032) & (K Units) Figure 5. 10ml Image Figure 6. Global 10ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 3ml Image Figure 8. Global 3ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Insulin Glulisine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Insulin Glulisine Injection Market Share by Type 2025 VS 2032 Figure 11. North America Insulin Glulisine Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Insulin Glulisine Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Insulin Glulisine Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Insulin Glulisine Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Insulin Glulisine Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Insulin Glulisine Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Insulin Glulisine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Insulin Glulisine Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Insulin Glulisine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Insulin Glulisine Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Insulin Glulisine Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Insulin Glulisine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Insulin Glulisine Injection Market Share by Application 2025 VS 2032 Figure 31. North America Insulin Glulisine Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Insulin Glulisine Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Insulin Glulisine Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Insulin Glulisine Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Insulin Glulisine Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Insulin Glulisine Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Insulin Glulisine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Insulin Glulisine Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Insulin Glulisine Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Insulin Glulisine Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Insulin Glulisine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Insulin Glulisine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Insulin Glulisine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Insulin Glulisine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Insulin Glulisine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Insulin Glulisine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Insulin Glulisine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Insulin Glulisine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Insulin Glulisine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Insulin Glulisine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Insulin Glulisine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Insulin Glulisine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Insulin Glulisine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Insulin Glulisine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Insulin Glulisine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Insulin Glulisine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Insulin Glulisine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Insulin Glulisine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Insulin Glulisine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Insulin Glulisine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Insulin Glulisine Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Insulin Glulisine Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml
  • 3ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lilly and Company
  • Dongyangguang Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Glulisine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Glulisine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Glulisine Injection Market by Type
  6. 1.3.1 10ml
  7. 1.3.2 3ml
  8. 1.4 Global Insulin Glulisine Injection Market Size by Type
  9. 1.4.1 Global Insulin Glulisine Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Insulin Glulisine Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Insulin Glulisine Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Insulin Glulisine Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Insulin Glulisine Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Insulin Glulisine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Insulin Glulisine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Insulin Glulisine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Glulisine Injection Industry Trends
  2. 2.2 Insulin Glulisine Injection Industry Drivers
  3. 2.3 Insulin Glulisine Injection Industry Opportunities and Challenges
  4. 2.4 Insulin Glulisine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Glulisine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Glulisine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Glulisine Injection Price (2021-2026)
  4. 3.4 Global Insulin Glulisine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Glulisine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Glulisine Injection Company, Product Type & Application
  7. 3.7 Global Insulin Glulisine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Glulisine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Glulisine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Glulisine Injection Tier 1, Tier 2, and Tier 3
4 Insulin Glulisine Injection Regional Status and Outlook
  1. 4.1 Global Insulin Glulisine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Glulisine Injection Historic Market Size by Region
  3. 4.2.1 Global Insulin Glulisine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Glulisine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Glulisine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Glulisine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Glulisine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Glulisine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Glulisine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Glulisine Injection by Application
  1. 5.1 Insulin Glulisine Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Insulin Glulisine Injection Market Size by Application
  6. 5.2.1 Global Insulin Glulisine Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Insulin Glulisine Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Insulin Glulisine Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Insulin Glulisine Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Insulin Glulisine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Insulin Glulisine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Insulin Glulisine Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Insulin Glulisine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Insulin Glulisine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Insulin Glulisine Injection Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Insulin Glulisine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Insulin Glulisine Injection Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Insulin Glulisine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Insulin Glulisine Injection Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Dongyangguang Pharmaceuticals
  20. 6.4.1 Dongyangguang Pharmaceuticals Company Information
  21. 6.4.2 Dongyangguang Pharmaceuticals Business Overview
  22. 6.4.3 Dongyangguang Pharmaceuticals Insulin Glulisine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dongyangguang Pharmaceuticals Insulin Glulisine Injection Product Portfolio
  24. 6.4.5 Dongyangguang Pharmaceuticals Recent Developments
  25. 6.5 Gan & Lee Pharmaceuticals
  26. 6.5.1 Gan & Lee Pharmaceuticals Company Information
  27. 6.5.2 Gan & Lee Pharmaceuticals Business Overview
  28. 6.5.3 Gan & Lee Pharmaceuticals Insulin Glulisine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gan & Lee Pharmaceuticals Insulin Glulisine Injection Product Portfolio
  30. 6.5.5 Gan & Lee Pharmaceuticals Recent Developments
  31. 6.6 Biocon
  32. 6.6.1 Biocon Company Information
  33. 6.6.2 Biocon Business Overview
  34. 6.6.3 Biocon Insulin Glulisine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Biocon Insulin Glulisine Injection Product Portfolio
  36. 6.6.5 Biocon Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Glulisine Injection Sales by Country
  2. 7.1.1 North America Insulin Glulisine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Glulisine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Glulisine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Glulisine Injection Market Size by Country
  6. 7.2.1 North America Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Glulisine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Glulisine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Glulisine Injection Sales by Country
  2. 8.1.1 Europe Insulin Glulisine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Glulisine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Glulisine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Glulisine Injection Market Size by Country
  6. 8.2.1 Europe Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Glulisine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Glulisine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Glulisine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Glulisine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Glulisine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Glulisine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Glulisine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Glulisine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Glulisine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Glulisine Injection Sales by Country
  2. 10.1.1 South America Insulin Glulisine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Glulisine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Glulisine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Glulisine Injection Market Size by Country
  6. 10.2.1 South America Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Glulisine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Glulisine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Glulisine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Glulisine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Glulisine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Glulisine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Glulisine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Glulisine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Glulisine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Glulisine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Glulisine Injection Value Chain Analysis
  2. 12.1.1 Insulin Glulisine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Glulisine Injection Production Mode & Process
  7. 12.2 Insulin Glulisine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Glulisine Injection Distributors
  10. 12.2.3 Insulin Glulisine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst